We are live on ! Find out more
NGM

North Growth Management Portfolio holdings

AUM $780M
1-Year Est. Return 102.77%
This Fund
S&P 500
This Quarter Est. Return
+12.4%
1 Year Est. Return
+102.77%
3 Year Est. Return
+230.6%
5 Year Est. Return
+253.58%
10 Year Est. Return
AUM
$469M
AUM Growth
+$18M
Cap. Flow
-$28.4M
Cap. Flow %
-6.06%
Top 10 Hldgs %
40.94%
Holding
51
New
2
Increased
9
Reduced
4
Closed
4

Top Buys

Rank Stock Value
1
ITGR icon
Integer Holdings
ITGR
+$7.92M
2
TMO icon
Thermo Fisher Scientific
TMO
+$7.74M
3
INMD icon
InMode
INMD
+$3.3M
4
SEDG icon
SolarEdge
SEDG
+$2.73M
5
ARHS icon
Arhaus
ARHS
+$2.05M

Sector Composition

Rank Sector Weight
1 Technology 44.53%
2 Consumer Discretionary 20.06%
3 Industrials 16.9%
4 Healthcare 15.08%
5 Communication Services 3.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRL icon
26
Charles River Laboratories
CRL
$13.9B
$8.76M 1.87%
37,000
EA
27
DELISTED
Electronic Arts
EA
$8.63M 1.84%
63,000
TMO icon
28
Thermo Fisher Scientific
TMO
$230B
$8.6M 1.83%
+16,000
New +$7.74M
AAPL icon
29
Apple
AAPL
$4.67T
$8.51M 1.82%
44,000
TXN icon
30
Texas Instruments
TXN
$236B
$8.41M 1.79%
49,000
SEDG icon
31
SolarEdge
SEDG
$1.93B
$7.59M 1.62%
81,000
+30,000
+59% +$2.73M
WBD icon
32
Warner Bros
WBD
$72.1B
$7.46M 1.59%
655,000
+80,000
+14% +$864K
WTS icon
33
Watts Water Technologies
WTS
$12.2B
$7.45M 1.59%
36,000
URI icon
34
United Rentals
URI
$64.1B
$6.55M 1.4%
11,000
CROX icon
35
Crocs
CROX
$5.86B
$6.43M 1.37%
69,000
ODFL icon
36
Old Dominion Freight Line
ODFL
$41.2B
$6.13M 1.31%
30,000
+6,000
+25% +$1.19M
ULTA icon
37
Ulta Beauty
ULTA
$22.1B
$5.87M 1.25%
12,000
ATKR icon
38
Atkore
ATKR
$3.16B
$5.77M 1.23%
36,000
+12,000
+50% +$1.66M
ARHS icon
39
Arhaus
ARHS
$1.27B
$5.74M 1.22%
484,000
+218,000
+82% +$2.05M
RH icon
40
RH
RH
$2.83B
$5.69M 1.21%
20,000
-7,000
-26% -$1.81M
WST icon
41
West Pharmaceutical
WST
$23.7B
$4.34M 0.93%
12,000
+2,000
+20% +$708K
BIIB icon
42
Biogen
BIIB
$32.3B
$2.95M 0.63%
11,000
MBC icon
43
MasterBrand
MBC
$1.76B
$2.68M 0.57%
181,000
AXNX
44
DELISTED
Axonics, Inc. Common Stock
AXNX
$1.59M 0.34%
26,000
CSIQ icon
45
Canadian Solar
CSIQ
$892M
$1.34M 0.29%
51,000
+4,000
+9% +$88.3K
ZYME icon
46
Zymeworks
ZYME
$2.02B
$1.01M 0.21%
97,000
LULU icon
47
lululemon athletica
LULU
$13.7B
0
BBY icon
48
Best Buy
BBY
$17.4B
-130,000
Closed -$9.04M
BMY icon
49
Bristol-Myers Squibb
BMY
$136B
-195,000
Closed -$11.3M
RVTY icon
50
Revvity
RVTY
$14.4B
-59,000
Closed -$6.5M

Similar funds

North Growth Management's Q4 2023 Portfolio in Review

As of Q4 2023, North Growth Management held 51 positions worth $469M, up 4% from $451M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

North Growth Management withdrew a net $28.4M in Q4 2023, closing 4 positions and reducing 4 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $18.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 43% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, North Growth Management opened a new position in Integer Holdings worth $9.15M.

  • North Growth Management's largest Q4 2023 buy was Integer Holdings: 92,000 shares worth $9.15M.
  • North Growth Management added most to InMode in Q4 2023, an estimated $3.3M increase.
  • North Growth Management's biggest Q4 2023 reduction was Jabil, cutting an estimated $7.13M.
  • North Growth Management fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $18.9M.
  • North Growth Management's ten largest holdings make up 41% of its $469M portfolio in Q4 2023.
  • North Growth Management opened 2 new positions and closed 4 in Q4 2023.
  • North Growth Management's portfolio value rose 4% quarter-over-quarter to $469M.

Based on North Growth Management's 13F filing for Q4 2023, filed 7 Feb 2024.